טוען...
MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas
Blood-based biomarkers for early detection of colorectal cancer (CRC) could complement current approaches to CRC screening. We previously identified the APC-binding protein MAPRE1 as a potential CRC biomarker. Here we undertook a case-control validation study to determine the performance of MAPRE1 i...
שמור ב:
| הוצא לאור ב: | Cancer Prev Res (Phila) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4633385/ https://ncbi.nlm.nih.gov/pubmed/26342024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-15-0077 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|